Axonyx, Inc.
Records under this name other than patents Axonyx, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 7 of 7 · Back to Axonyx, Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,994,210 | Method of treating Down Syndrome Lapsed on the fee record Ended Aug 9, 2023 · From the USPTO record | Lapsed on the fee record | Ended Aug 9, 2023 | From the USPTO record |
| US 7,153,882 | Agents Useful for Reducing Amyloid Precursor Protein and Treating Demantia and Methods of Use Thereof Term ended Term ended Dec 23, 2022 · High confidence | Term ended | Term ended Dec 23, 2022 | High confidence |
| US 6,495,700 | Process for producing phenserine and its analog Formerly held Term ended Term ended Jan 9, 2022 · From the USPTO record | Term ended | Term ended Jan 9, 2022 | From the USPTO record |
| US 7,625,942 | Method of treating Down syndrome Lapsed on the fee record Ended Dec 1, 2021 · From the USPTO record | Lapsed on the fee record | Ended Dec 1, 2021 | From the USPTO record |
| US 6,410,747 | Highly selective butyrylcholinesterase inhibitors for the treatment and diagnosis of alzheimer's disease and dementias Formerly held Term ended Term ended Jun 17, 2019 · From the USPTO record | Term ended | Term ended Jun 17, 2019 | From the USPTO record |
| US 6,683,105 | Highly Selective Butyrylcholinesterase Inhibitors for the Treatment and Diagnosis of Alzheimer's Disease and Dementias Formerly held Lapsed on the fee record Ended Jan 27, 2016 · Medium confidence | Lapsed on the fee record | Ended Jan 27, 2016 | Medium confidence |
| US 6,689,753 | &bgr; sheet breaker peptide analogs that inhibit &bgr; pleated sheet formation in amyloid &bgr;-peptide Lapsed on the fee record Ended Feb 10, 2008 · From the USPTO record | Lapsed on the fee record | Ended Feb 10, 2008 | From the USPTO record |